Selective erythroid aplasia during therapy for acute lymphoblastic leukemia.
Selective erythroid aplasia occured in two children receiving chemotherapy for acute lymphoblastic leukemia. The aplasia was reversible on cessation of therapy in one patient, and the other child remains transfusion-dependent on chemotherapy. Possible causes of pure red cell aplasia are discussed.
D000208:Acute Disease; D000740:Anemia / Q000150:complications* / Q000209:etiology; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D004920:Erythropoiesis; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008297:Male; D012075:Remission, Spontaneous
D000970:Antineoplastic Agents